Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01002190

CERILLIANT™ Zonisamide-13C6 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™

Certified reference material

Supplier:  MilliporeSigma Supelco Z0061ML

Catalog No. 01-002-190


Explore available promotions
Add to Cart

Description

Description

Zonisamide is a second-generation anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed seizure types of Lennox-Gastaut syndrome, and generalized tonic clonic seizure. Zonisamide is marketed in the US under the trade name Zonegran™.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

67-56-1, 1435934-68-1
UN 1230 - class 3 - PG 2 - Methanol, solution
218.18
1 mL
13C6C2H8N2O3S
100 μg/mL in methanol
Ampule
9.7°C (49.5°F) - closed cup
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

H331-H370

H311

EINECSNumber : 200-659-6

Recommended Storage : -20°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.

CERILLIANT is a registered trademark of Cerilliant Corporation